Current medical therapy and revascularization in peripheral artery disease of the lower limbs: impacts on subclinical chronic inflammation
AL Cecchini, F Biscetti, M Manzato, L Lo Sasso… - International Journal of …, 2023 - mdpi.com
Peripheral artery disease (PAD), coronary artery disease (CAD), and cerebrovascular
disease (CeVD) are characterized by atherosclerosis and inflammation as their underlying …
disease (CeVD) are characterized by atherosclerosis and inflammation as their underlying …
Novel strategies to promote resolution of inflammation to treat lower extremity artery disease
Q Zhang, F Li, RH Ritchie, OL Woodman, X Zhou… - Current Opinion in …, 2022 - Elsevier
Lower extremity artery disease (LEAD) is a chronic inflammatory disease that occurs when
atherosclerotic plaques form in the lower extremities, which may lead to amputation if not …
atherosclerotic plaques form in the lower extremities, which may lead to amputation if not …
Pharmacotherapy and revascularization strategies of peripheral artery disease
E Moras, M Khan, DD Song, M Syed… - Current Problems in …, 2024 - Elsevier
The global epidemiological transition of atherosclerotic vascular diseases is witnessing a
rapid redistribution of its burden, shifting from high-income to low-and middle-income …
rapid redistribution of its burden, shifting from high-income to low-and middle-income …
Integrating mechanisms in thrombotic peripheral arterial disease
Peripheral arterial disease (PAD), a manifestation of systemic atherosclerosis, is
underdiagnosed in the general population. Despite the extensive research performed to …
underdiagnosed in the general population. Despite the extensive research performed to …
Inflammatory biomarkers in peripheral artery disease: diagnosis, prognosis, and therapeutic challenges
Y Ozaki, T Imanishi, T Akasaka - Current Medicinal Chemistry, 2015 - ingentaconnect.com
Peripheral artery disease (PAD) is an inflammatory disease caused by atherosclerosis. It
has been demonstrated that PAD is related to chronic inflammation. While conventional risk …
has been demonstrated that PAD is related to chronic inflammation. While conventional risk …
Update on the pathophysiology and medical treatment of peripheral artery disease
J Golledge - Nature reviews cardiology, 2022 - nature.com
Approximately 6% of adults worldwide have atherosclerosis and thrombosis of the lower
limb arteries (peripheral artery disease (PAD)) and the prevalence is rising. PAD causes leg …
limb arteries (peripheral artery disease (PAD)) and the prevalence is rising. PAD causes leg …
Inflammation in peripheral arterial disease (PAD)
S Santo Signorelli, M Anzaldi… - Current pharmaceutical …, 2012 - ingentaconnect.com
Peripheral arterial disease (PAD) affects a large number of individuals over the age of 55
years old, and data from studies has shown a relationship between inflammation, and PAD …
years old, and data from studies has shown a relationship between inflammation, and PAD …
Management and Pharmacological Treatment of Peripheral Arterial Disease
SJ Leatham, KR Winckel… - Journal of Pharmacy …, 2024 - journals.sagepub.com
Background: Peripheral arterial disease (PAD) is a complex, heterogeneous condition that
has become a leading health concern globally. Peripheral arterial disease often co-exists …
has become a leading health concern globally. Peripheral arterial disease often co-exists …
[HTML][HTML] Peripheral Artery Disease: Underappreciated Impact and Residual Cardiovascular Risk Despite Revascularization
This Commentary highlights the under-recognized prevalence and heavy burden of
peripheral artery disease (PAD) and its important role as a harbinger of complications of …
peripheral artery disease (PAD) and its important role as a harbinger of complications of …
Preventive therapies in peripheral arterial disease
AJ Shah, N Pavlatos, DK Kalra - Biomedicines, 2023 - mdpi.com
Atherosclerosis, while initially deemed a bland proliferative process, is now recognized as a
multifactorial-lipoprotein-mediated inflammation-driven pathway. With the rising incidence of …
multifactorial-lipoprotein-mediated inflammation-driven pathway. With the rising incidence of …